Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP226549.RAVp9OwloKdS12q1aIeFsuueCpZMqv-wHnjf7Uc14srko130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP226549.RAVp9OwloKdS12q1aIeFsuueCpZMqv-wHnjf7Uc14srko130_assertion type Assertion NP226549.RAVp9OwloKdS12q1aIeFsuueCpZMqv-wHnjf7Uc14srko130_head.
- NP226549.RAVp9OwloKdS12q1aIeFsuueCpZMqv-wHnjf7Uc14srko130_assertion description "[Mutations in GLUD1, HADH, GCK and HNF4A genes were sought in patients with diazoxide-responsive CHI with hyperammonaemia (GLUD1), raised 3-hydroxybutyrylcarnitine and/or consanguinity (HADH), positive family history (GCK) or when CHI was diagnosed within the first week of life (HNF4A).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP226549.RAVp9OwloKdS12q1aIeFsuueCpZMqv-wHnjf7Uc14srko130_provenance.
- NP226549.RAVp9OwloKdS12q1aIeFsuueCpZMqv-wHnjf7Uc14srko130_assertion evidence source_evidence_literature NP226549.RAVp9OwloKdS12q1aIeFsuueCpZMqv-wHnjf7Uc14srko130_provenance.
- NP226549.RAVp9OwloKdS12q1aIeFsuueCpZMqv-wHnjf7Uc14srko130_assertion SIO_000772 23345197 NP226549.RAVp9OwloKdS12q1aIeFsuueCpZMqv-wHnjf7Uc14srko130_provenance.
- NP226549.RAVp9OwloKdS12q1aIeFsuueCpZMqv-wHnjf7Uc14srko130_assertion wasDerivedFrom befree-20140225 NP226549.RAVp9OwloKdS12q1aIeFsuueCpZMqv-wHnjf7Uc14srko130_provenance.
- NP226549.RAVp9OwloKdS12q1aIeFsuueCpZMqv-wHnjf7Uc14srko130_assertion wasGeneratedBy ECO_0000203 NP226549.RAVp9OwloKdS12q1aIeFsuueCpZMqv-wHnjf7Uc14srko130_provenance.